These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L. Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847 [Abstract] [Full Text] [Related]
8. Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy. Bové T, Van Belleghem Y, Vandenplas G, Caes F, François K, De Backer J, De Pauw M, Van Nooten G. Eur J Cardiothorac Surg; 2009 Jun; 35(6):995-1003; discussion 1003. PubMed ID: 19136274 [Abstract] [Full Text] [Related]
9. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy. Ng AC, Sindone AP, Wong HS, Freedman SB. Int J Cardiol; 2008 Sep 26; 129(2):198-204. PubMed ID: 17706807 [Abstract] [Full Text] [Related]
10. Clinical and haemodynamic effects of oral metoprolol therapy in dilated cardiomyopathy. Nair M, Sethi KK, Agrawal R, Arora R, Khalilullah M. Indian Heart J; 1990 Sep 26; 42(6):411-4. PubMed ID: 2098312 [Abstract] [Full Text] [Related]
13. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Seghatol FF, Shah DJ, Diluzio S, Bello D, Johnson MR, Cotts WG, O'Donohue JA, Bonow RO, Gheorghiade M, Rigolin VH. Am J Cardiol; 2004 Apr 01; 93(7):854-9. PubMed ID: 15050488 [Abstract] [Full Text] [Related]
14. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy. Zecchin M, Di Lenarda A, Gregori D, Moretti M, Driussi M, Aleksova A, Chersevani D, Sabbadini G, Sinagra G. Ital Heart J; 2005 Sep 01; 6(9):721-7. PubMed ID: 16212073 [Abstract] [Full Text] [Related]
16. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy. Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G. Europace; 2004 Sep 01; 6(5):400-6. PubMed ID: 15294264 [Abstract] [Full Text] [Related]
17. [Improvement of prognosis in idiopathic dilated cardiomyopathy: role of early diagnosis and optimized medical treatment. Study Group on Heart Muscle Diseases]. Di Lenarda A, Hlede S, Sabbadini G, Davanzo M, Di Chiara C, Scherl G, Zanchi C, Sinagra G. G Ital Cardiol; 1999 Dec 01; 29(12):1452-62. PubMed ID: 10687108 [Abstract] [Full Text] [Related]
19. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor. Hamada M, Hara Y, Ohtsuka T, Suzuki J, Saeki H, Ogimoto A, Shigematsu Y. J Cardiovasc Pharmacol; 2003 Jan 01; 41 Suppl 1():S5-10. PubMed ID: 12688389 [Abstract] [Full Text] [Related]
20. Right ventricular function predicts transplant-free survival in idiopathic dilated cardiomyopathy. La Vecchia L, Varotto L, Zanolla L, Spadaro GL, Fontanelli A. J Cardiovasc Med (Hagerstown); 2006 Sep 01; 7(9):706-10. PubMed ID: 16932086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]